Navigation Links
Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit
Date:6/5/2008

Capital Returns, Inc., a GENCO Supply Chain Solutions' company, to present details of the nation's first-of-its-kind safe medicine disposal pilot during U.S. Environmental Protection Agency's (Region III) Pharmaceutical

Disposal Summit in Philadelphia.

PHILADELPHIA, June 5 /PRNewswire/ -- Capital Returns, Inc. (CRI), the pharmaceutical industry's leading processor of pharmaceutical returns, today announced that attendees at the Philadelphia area regional Pharmaceutical Disposal Summit will get a first look at a consumer medication return pilot program launched last month in a two-county area in Wisconsin. Sponsored by excelleRx and U.S. EPA Region III, the summit will include environmental and pharmaceutical executives who were invited to meet today in Philadelphia to discuss the critical issues surrounding pharmaceuticals in the environment.

CRI is set to brief attendees on "Get The Meds Out," the pioneering joint effort between the University of Wisconsin, the Wisconsin Department of Natural Resources and CRI.

The pilot program involves more than 500,000 potential participants in a two-county area. Consumers in Waukesha and Winnebago counties can call a special 800 number to receive a pre-paid shipping label. CRI will handle the calls, explain the process, provide a return authorization and send out a pre-paid label for the expired or unused medications, excluding controlled substances. Once consumers receive their pre-paid labels, they package their medicines for shipment back to CRI. Packages received by CRI are processed, separated and then disposed of through incineration. The entire process is free to consumers.

A research report published by the U.S. Geological Survey, determined that pharmaceuticals have been detected in multiple waterways throughout the U.S.

As the U.S. Drug Enforcement Agency begins its attempt to modify regulations that would potentially clear the way for more national and statewide medicine take-back programs, the significance of this first-of-its-kind pilot is already being established.

"We are honored to be invited to present our solution to pharmaceutical leaders here in Philadelphia," says Mary Hendrickson, director of Quality and Regulatory Affairs for CRI. "The Get The Meds Out program is creating national attention that will only help advance consumer understanding of the issue and ease the creation of a national medication return program in the future."

About Capital Returns, Inc.

CRI is the leader in pharmaceutical trade, sample and clinical trial returns and product recalls. CRI leverages its market position to transform pharmaceutical business activities into data-rich, systematic processes that provide critical business information and value to manufacturers, pharmacies and wholesalers. Through a state-of-the-art processing facility, CRI provides comprehensive pharmaceutical returns management services to over 40 pharmaceutical manufacturers, the biggest U.S. chain pharmacies, leading wholesalers and mail order pharmacies and specialty and infusion pharmacies. For more information, visit http://www.capitalreturns.com.


'/>"/>
SOURCE GENCO
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PSI Brings its Pioneering Efforts to a Close
2. American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
3. Boston IVF is First in Northeast to Offer Pioneering Test of Womens Biological Clock
4. Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Womens Biological Clock
5. WRAIR investigators pioneering work on an exciting new class of antimalarial compounds
6. Acclaimed A LION IN THE HOUSE Team Honored in Washington for Pioneering Work on Pediatric Cancer
7. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
8. Heart stem cell scientist to honor pioneering woman scientist in keynote speech
9. Kavli Prize awarded to Pasko Rakic, pioneering Yale neuroscientist
10. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
11. Manic phase of bipolar disorder benefits from breast cancer medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a ... Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South Africa. By ... to a patient’s remote health progress, empowering the patient to take direct responsibility for ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/25/2017)... ... 2017 , ... Bellus Medical, a leader in medical aesthetics, ... class of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically ... aging, and minimize the appearance of pores – all with minimal downtime and ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... and HR decision-makers are preparing for how his administration could impact the employee ... insight into what changes are most likely to make it through Congress. His ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... UNION CITY, Calif. , April 24, 2017 /PRNewswire/ ... providing durability, grip, protection, and comfort, announces the release ... the Powerform S8+. This most recent example of leading ... high density grip pattern for 200% more tactile grip ... in user protection and durability. With TracTek and a ...
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: